Back
Aptevo Therapeutics, Inc. Stock Predictions
Before There's a Price, There's a Position: NatGold Pre-Market
Secure your position now-before access is controlled by price.
Sell
19
APVO
Aptevo Therapeutics, Inc.
Last Price:
$6.65
Seasonality Move:
-19.22%
7 Day Trial
ALL ACCESS PASS
$
7
Bitcoin was First. NatGold is the Masterpiece.
Reserve Your Tokens NowAptevo Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Aptevo Therapeutics, Inc. has on average historically fallen by 32.1% based on the past 9 years of stock performance.
-
Aptevo Therapeutics, Inc. has fallen lower in 9 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Aptevo Therapeutics, Inc. Stock Undervalued?The current Aptevo Therapeutics, Inc. [APVO] share price is $7.54. The Score for APVO is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
APVO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Aptevo Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Aptevo Therapeutics, Inc. has on average historically fallen by 32.1% based on the past 9 years of stock performance.
Aptevo Therapeutics, Inc. Stock Rating
Sell
19
Aptevo Therapeutics, Inc. (APVO)
is a Sell
Is Aptevo Therapeutics, Inc. overpriced?
-
Aptevo Therapeutics, Inc. has fallen lower in 9 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Aptevo Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aptevotherapeutics.com
52-Week Data
52-Week High:
1,609.19
52-Week Low:
6.88
Prediction Charts
Market Cap:
127.1M
Price in USD:
7.54
Volume:
94.7K
Beta:
4.46
Technical Analysis
SMA50:
15.39
SMA100:
21.49
SMA200:
55.74
52-Wk Change:
-99.52%
Stock Predictions
-
Is Aptevo Therapeutics, Inc. stock public?Yes, Aptevo Therapeutics, Inc. is a publicly traded company.
-
What is the Aptevo Therapeutics, Inc. stock quote today?The Aptevo Therapeutics, Inc. stock price is 7.54 USD today.
-
How to buy Aptevo Therapeutics, Inc. stock online?You can buy Aptevo Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-13 | 8.83 | 8.88 | 9.05 | 8.49 |
| Jan-14 | 8.67 | 9.01 | 9.09 | 8.50 |
| Jan-15 | 8.92 | 9.03 | 9.10 | 8.55 |
| Jan-16 | 9.01 | 9.45 | 9.60 | 8.82 |
| Jan-20 | 9.26 | 9.83 | 10.70 | 9.02 |
| Jan-21 | 9.74 | 9.29 | 9.97 | 8.90 |
| Jan-22 | 9.10 | 8.93 | 9.39 | 8.83 |
| Jan-23 | 9.02 | 8.98 | 9.03 | 8.80 |
| Jan-26 | 9.11 | 8.81 | 9.11 | 8.72 |
| Jan-27 | 8.81 | 8.26 | 8.81 | 8.14 |
| Jan-28 | 8.28 | 7.84 | 8.28 | 7.81 |
| Jan-29 | 7.60 | 7.39 | 7.60 | 6.88 |
| Jan-30 | 7.35 | 7.27 | 7.38 | 7.06 |
| Feb-2 | 7.26 | 7.54 | 7.84 | 7.07 |
Aptevo Therapeutics, Inc. Earnings
Aptevo Therapeutics, Inc. Earnings Report: Per Share Aptevo Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Aptevo Therapeutics, Inc. Forecast Revenue Growth
Aptevo Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Aptevo Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $68.04 per share, and an increase next year of $0.90 per share.
* Aptevo Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.